You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Identification of SMYD2 as a candidate diagnostic and prognostic biomarker for gastric cancer
- 2. Breast cancer with gastric metastasis in invasive lobular carcinoma: a case report and literature review
- 3. Decoding colorectal cancer lung metastasis: a global research odyssey
- 4. Global research landscape of antiangiogenic therapy for colorectal cancer: a bibliometric analysis of mechanistic insights and clinical advancements
- 5. Case Report: Clinical impact of BRCA1 and BRIP1 vs. BRCA1 and BRCA2 germline double heterozygosity in ovarian cancer: a comparative case study
- 6. Clinical Prognosis and Nomograms for Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Patients Treated with Palbociclib and Endocrine Therapy
- 7. Beyond the mammogram: Study finds differences between benign and cancerous breast calcifications
- 8. Celcuity Announces First Patient Dosed in Phase 3 VIKTORIA-2 Clinical Trial of Gedatolisib as a First-Line Treatment for HR+/HER2- Advanced Breast Cancer
- 9. [Latest] Global CRISPR Gene Editing Market Size/Share Worth USD 12.6 Billion by 2034 at a 13.01% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
- 10. B7-H4 Targeting Therapies Market Growth Set to Accelerate Across the 7MM During the Study Period (2025-2040) with Advances in Immunotherapy | DelveInsight
Last updated at 1:56 GMT
Hot News Makers
Health/Pharma Companies
-
19053.39
-
14715.33
-
13282.90
-
11137.10
-
6781.89
-
6077.60
-
5780.72
-
5744.62
-
4495.08
-
4424.58
Drugs, Treatments, Trials
-
11561.58
-
5923.30
-
4893.22
-
4256.23
-
4232.24
-
2851.13
-
2413.29
-
2237.91
-
2138.45
-
2135.76
Last updated at 1:10 GMT
